We are studying a new treatment called U3-1402 for individuals with non-small cell lung cancer. The goal is to see how well it works compared to current therapies.
Health conditions and diseases that the clinical trial is designed to study and treat.
Metastatic Non-Small Cell Lung Cancer (NSCLC) is a type of lung cancer that has spread beyond the lungs to other parts of the body and cannot be surgically removed. It is the most common form of lung cancer and can be challenging to treat.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.